Your browser doesn't support javascript.
loading
Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma.
Rahbari, Kian J; Nosrati, Jason D; Spektor, Tanya M; Berenson, James R.
Affiliation
  • Rahbari KJ; James R. Berenson, MD, Inc, West Hollywood, CA.
  • Nosrati JD; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA.
  • Spektor TM; Oncotherapeutics, West Hollywood, CA.
  • Berenson JR; James R. Berenson, MD, Inc, West Hollywood, CA; Institute for Myeloma and Bone Cancer Research, West Hollywood, CA; Oncotherapeutics, West Hollywood, CA. Electronic address: jberenson@imbcr.org.
Clin Lymphoma Myeloma Leuk ; 18(9): e339-e343, 2018 09.
Article in En | MEDLINE | ID: mdl-30033209
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Canada Country of publication: United States